IRCT20101130005280N32
Recruiting
Phase 2
Evaluation of efficacy of levetiracetam on cognitive symptoms in schizophrenic patients
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- schizophrenic.
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •6\-month to 10\-year history of schizophrenia
- •Have a normal IQ
- •Do not be in the acute phase of schizophrenia.
- •The patient do not take anticholinergic and benzodiazepine medications
- •do not history of drug use in the past 6 months (except nicotine)
- •Do not be pregnant or breastfeeding (Pregnancy Detection Based on BHCG Pregnancy Test)
Exclusion Criteria
- •Lack of consent for participation in the study
- •Serious medical illness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Evaluation of the effect of Levetiracetam on cognitive impairment in patients with MSIRCT20210707051810N2Tehran University of Medical Sciences88
Not yet recruiting
Not Applicable
Phenobarbitone vs Levetiracetam in term asphyxiated babies.CTRI/2020/05/025416Department of Neonatology
Completed
Not Applicable
To investigate the effects of levetiracetam on the rehabilitation outcome in patients with cerebral infarctiocerebral infarctionJPRN-UMIN000033761Yamanashi Rehabilitation Hospital30
Completed
Phase 4
The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled StudyFocal EpilepsyNCT02208492Yonsei University75
Completed
Not Applicable
Study on efficacy and safety of levetiracetam administration by nasogastric tube in patients with convulsive status epilepticusConvulsive status epilepticusJPRN-UMIN000010552Department of Emergency and Critical Care Medicine, Wakayama Medical University20